menu search

Harpoon therapeutics to present interim tolerability and response data from phase 1/2 clinical trial of t cell engager hpn328 at esmo congress 2023

SOUTH SAN FRANCISCO, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company deve...

October 9, 2023, 4:17 pm

Biorestorative therapies, inc. to participate at the roth mkm healthcare opportunities conference october 12, 2023 in new york city

MELVILLE, NY., Oct. 09, 2023 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRetorative”) (NASDAQ: BRTX), a clinical...

October 9, 2023, 4:10 pm

Akero therapeutics to present results from phase 2b symmetry study investigating efruxifermin in patients with compensated cirrhosis due to nash

Investor webcast on Tuesday, October 10 at 8:00 a.m. ET to present clinical data Investor webcast on Tuesday, October 10 at 8:00 a.m. ET to present cl...

October 9, 2023, 4:05 pm

Fiber cement board market surges amidst retrofitting and new building investments, set to reach us$ 16,890 million by 2033: fmi forecast

The construction and real estate industry’s rapid expansion is poised to drive indirect growth in fiber cement board sales, as increased renovation ...

October 9, 2023, 2:30 pm

China's economy is coming back through small incremental reforms, says kraneshares' brendan ahern

Brendan Ahern, KraneShares CIO, joins 'The Exchange' to discuss the real estate crisis in China, the pat...

October 9, 2023, 2:27 pm

J&j (jnj) seeks eu nod for rybrevant for first-line nsclc

J&J (JNJ) files an application in Europe seeking expanded approval for Rybrevant as a first-line combination treatment in ...

October 9, 2023, 12:46 pm

Middle east tensions elevate safe havens, but gains in yen and franc restrained

The global financial markets are responding with caution to the rising tensions in the Middle East. However, this sentiment is tempered and contained,...

October 9, 2023, 12:42 pm

Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun...

October 9, 2023, 12:10 pm

Veradigm (mdrx)-fdb vela to enhance pharmacy connectivity

Veradigm's (MDRX) latest progress with FDB Vela is likely to offer prescribers and patients greater cho...

October 9, 2023, 12:02 pm

Rivian still tipped to ‘outperform' but this bull says investors patience is wearing thin

Rivian Automotive Inc's (NASDAQ:RIVN) growth and demand story looks solid heading into the fourth quarter, according to analysts at Wedbush, as they r...

October 9, 2023, 11:43 am

Why patterson-uti (pten) is a top value stock for the long-term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

October 9, 2023, 11:17 am

Plus therapeutics to participate in the jones trading healthcare summit and thinkequity conference in october

AUSTIN, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company ...

October 9, 2023, 11:00 am

Alnylam stock is dropping on surprising fda rejection

Drugmaker Alnylam wanted to expand approval of its drug Onpattro, but the Food and Drug Administration ...

October 9, 2023, 10:34 am

Arcutis (arqt) up on fda nod for zoryve label expansion

Arcutis (ARQT) gains on receiving FDA approval for label expansion of Zoryve (roflumilast) cream 0.3% to treat ...

October 9, 2023, 10:31 am

7 dividend stocks ready to roar into 2024

In the ever-evolving financial realm, dividend stocks to buy continue to hold a revered space in a savvy investor's portfolio. These dividend-yielding...

October 9, 2023, 10:06 am

Cintas corporation to participate in upcoming investor conference

CINCINNATI--(BUSINESS WIRE)--Cintas Corporation (Nasdaq: CTAS) announced that its Executive Vice President and Chief Financial Officer, Mike Hansen, a...

October 9, 2023, 9:58 am

Viavi's positioning in 5g: promising, but stock is expensive

Viavi Solutions is a network testing and monitoring company with a diversified portfolio covering three essential business segments. VIAV faces compet...

October 9, 2023, 9:49 am

Apa expects strong q3 production and oil output amid challenges

APA anticipates strong Q3 results, driven by Permian oil and U.K. North Sea output, with favorable pric...

October 9, 2023, 9:46 am

Hormel foods announces webcast of 2023 investor day presentation

AUSTIN, Minn. , Oct. 9, 2023 /PRNewswire/ -- Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, invites interested parti...

October 9, 2023, 9:25 am

Ehang voluntarily suspends trading on stock pending ‘very significant development'

EHang Holdings Ltd. EH, +5.36% said Monday it won approval from the Nasdaq to voluntarily delist its stock on a temporary basis “in antici...

October 9, 2023, 9:24 am


Search within

Pages Search Results: